Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
23,046.80
(
-1.98%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
101.43
(
2.69%
)
Bitcoin
69,109.35
(
-3.08%
)
News Focus
News Focus
Post# of 257294
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122814
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: anesthesia doc post# 222609

Tuesday, 12/04/2018 9:10:08 AM

Tuesday, December 04, 2018 9:10:08 AM

Post# of 257294
Re: RVNC-Fosun deal

Selling the rights to market RT002 in China for up to $260 million seems low to me.

RVNC’s economic interest in the Fosun deal is not $260M, but rather $260M plus royalties.

Isn’t China supposed to be the fastest growing market for Botox?

China is indeed a fast-growth market for botulinum toxin products generally, but there are several knockoff brands competing for share.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today